2024/09/26 17:31:24 | |
---|---|
Price | |
0.0726 CHF | |
Difference | -2.42% (-0.00) |
ISIN | CH0029850754 |
Symbol | ADXN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 0.069 CHF (12,355) |
Ask (Ask size) | 0.0726 CHF (100) |
Open | 0.0744 CHF |
High | 0.0744 CHF |
Low | 0.0686 CHF |
Close (prev. day) | 0.0744 CHF |
VWAP | 0.071226 CHF |
Volume (pcs) | 11,499 |
Trading volume | 819.03 |
Number of trades | 4 |
Last size | 298 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/26 17:31:24 | |
---|---|
Price | |
0.0726 CHF | |
Difference | -2.42% (-0.00) |
ISIN | CH0029850754 |
Symbol | ADXN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 0.069 CHF (12,355) |
Ask (Ask size) | 0.0726 CHF (100) |
Open | 0.0744 CHF |
High | 0.0744 CHF |
Low | 0.0686 CHF |
Close (prev. day) | 0.0744 CHF |
VWAP | 0.071226 CHF |
Volume (pcs) | 11,499 |
Trading volume | 819.03 |
Number of trades | 4 |
Last size | 298 |
6m | 1Y | 3Y | |
Perf (%) | -23.42% | +11.01% | -95.16% |
Perf (abs.) | -0.02 | +0.01 | -1.43 |
Beta | 0.45 | 1.06 | 0.83 |
Volatility | 143.88 | 124.85 | 111.38 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.0736 CHF (201,059) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.0699 CHF (568,894) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.0653 CHF (296,489) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.0696 CHF (598,996) |
YTD High | date | 0.2600 CHF (2024/04/09) |
YTD Low | date | 0.0450 CHF (2024/01/03) |
52 Weeks High | date | 0.2600 CHF (2024/04/09) |
52 Weeks Low | date | 0.0362 CHF (2023/11/29) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2019/06/28 | 15:58 | 1.37 EUR | 0.00 | 5 |
Frankfurt | 2019/06/28 | 17:14 | 1.355 EUR | 0.00 | 7 |
London Stock Exchange | 2024/05/02 | 17:55 | 0.064 CHF | 0.01 | 1 |
SIX Swiss Exchange | 2024/09/26 | 17:31 | 0.0726 CHF | 0.00 | 4 |
Stuttgart | 2019/06/28 | 15:43 | 1.37 EUR | 0.00 | 7 |
ADDEX THERAPEUTICS LTD. |
- - |
9, Chemin des Mines, Plan-les-Ouates - 1202 Genf |
Telefon: +41-22-884-15-55 |
Fax: +41-22-884-15-56 |
E-mail: info@addextherapeutics.com |
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland. |
Timothy Dyer | Chairman of Managing Board |
Lénaic Teyssédou | Member of Executive Committee |
Mikhail Kalinichev | Member of Executive Committee |
Roger Mills | Member of Executive Committee |
Isaac Manke | Member of the administrative board |
Raymond Hill | Member of the administrative board |
Roger Mills | Member of the administrative board |
Jake Nunn | Member of the administrative board |
Vincent Lawton | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer